Clinical Trial Update: Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating glucocorticoids in combination with rituximab for newly diagnosed or relapsing IgA vasculitis; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Vasculitis

Drugs mentioned

• Rituxan (rituximab)
• glucocorticoids (glucocorticoids)

Snippet

Sponsor: Hopital Foch | Conditions: IgA Vasculitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING